Literature DB >> 22836057

Randomized, multicenter trial on the effect of radiation therapy on plantar fasciitis (painful heel spur) comparing a standard dose with a very low dose: mature results after 12 months' follow-up.

Marcus Niewald1, M Heinrich Seegenschmiedt, Oliver Micke, Stefan Graeber, Ralf Muecke, Vera Schaefer, Christine Scheid, Jochen Fleckenstein, Norbert Licht, Christian Ruebe.   

Abstract

PURPOSE: To conduct a randomized trial of radiation therapy for painful heel spur, comparing a standard dose with a very low dose. METHODS AND MATERIALS: Sixty-six patients were randomized to receive radiation therapy either with a total dose of 6.0 Gy applied in 6 fractions of 1.0 Gy twice weekly (standard dose) or with a total dose of 0.6 Gy applied in 6 fractions of 0.1 Gy twice weekly (low dose). In all patients lateral opposing 4- to 6-MV photon beams were used. The results were measured using a visual analogue scale, the Calcaneodynia score, and the SF12 health survey. The fundamental phase of the study ended after 3 months, and the follow-up was continued up to 1 year. Patients with insufficient pain relief after 3 months were offered reirradiation with the standard dosage at any time afterward.
RESULTS: Of 66 patients, 4 were excluded because of withdrawal of consent or screening failures. After 3 months the results in the standard arm were highly significantly superior compared with those in the low-dose arm (visual analogue scale, P=.001; Calcaneodynia score, P=.027; SF12, P=.045). The accrual of patients was stopped at this point. Further evaluation after 12 months' follow-up showed the following results: (1) highly significant fewer patients were reirradiated in the standard arm compared with the low-dose arm (P<.001); (2) the results of patients in the low-dose arm who were reirradiated were identical to those in the standard arm not reirradiated (reirradiation as a salvage therapy if the lower dose was ineffective); (3) patients experiencing a favorable result after 3 months showed this even after 12 months, and some results even improved further between 3 and 12 months.
CONCLUSIONS: This study confirms the superior analgesic effect of radiation therapy with 6-Gy doses on painful heel spur even for a longer time period of at least 1 year.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22836057     DOI: 10.1016/j.ijrobp.2012.06.022

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  24 in total

1.  Low-dose radiotherapy: Mayday, mayday. We've been hit!

Authors:  Oliver J Ott; Oliver Micke; Ralph Mücke; Marcus Niewald; Franz Rödel; Ulrich Schäfer; M H Seegenschmiedt; Meritxell Arenas; Benjamin Frey; Udo S Gaipl
Journal:  Strahlenther Onkol       Date:  2018-12-18       Impact factor: 3.621

2.  Low-dose analgesic radiotherapy is a real alternative.

Authors:  Ralph Mücke; Oliver Micke; Ulrich Schäfer; Michael Heinrich Seegenschmiedt
Journal:  Dtsch Arztebl Int       Date:  2013-01-07       Impact factor: 5.594

3.  Re-irradiation for painful heel spur syndrome. Retrospective analysis of 101 heels.

Authors:  M G Hautmann; U Neumaier; O Kölbl
Journal:  Strahlenther Onkol       Date:  2014-01-24       Impact factor: 3.621

4.  Successful treatment of chronic recurrent multifocal osteomyelitis using low-dose radiotherapy : A case report.

Authors:  Christian T Dietzel; Christoph Schäfer; Dirk Vordermark
Journal:  Strahlenther Onkol       Date:  2016-11-07       Impact factor: 3.621

Review 5.  Radiotherapy for benign disease; assessing the risk of radiation-induced cancer following exposure to intermediate dose radiation.

Authors:  Stephanie R McKeown; Paul Hatfield; Robin J D Prestwich; Richard E Shaffer; Roger E Taylor
Journal:  Br J Radiol       Date:  2015-10-14       Impact factor: 3.039

6.  Radiotherapy of painful heel spur with two fractionation regimens : Results of a randomized multicenter trial after 48 weeks' follow-up.

Authors:  Benjamin Prokein; Henrik Holtmann; Matthias G Hautmann; Hans-Peter Rösler; Stefan Graeber; Yvonne Dzierma; Christian Ruebe; Jochen Fleckenstein; Marcus Niewald
Journal:  Strahlenther Onkol       Date:  2017-02-27       Impact factor: 3.621

Review 7.  DEGRO guidelines for the radiotherapy of non-malignant disorders. Part II: Painful degenerative skeletal disorders.

Authors:  Oliver J Ott; Marcus Niewald; Hajo-Dirk Weitmann; Ingrid Jacob; Irenaeus A Adamietz; Ulrich Schaefer; Ludwig Keilholz; Reinhard Heyd; Ralph Muecke
Journal:  Strahlenther Onkol       Date:  2014-09-20       Impact factor: 3.621

8.  The field size matters: low dose external beam radiotherapy for thumb carpometacarpal osteoarthritis : Importance of field size.

Authors:  Alexander Kaltenborn; Elke Bulling; Mirko Nitsche; Ulrich Martin Carl; Robert Michael Hermann
Journal:  Strahlenther Onkol       Date:  2016-06-14       Impact factor: 3.621

9.  Radiotherapy for benign achillodynia. Long-term results of the Erlangen Dose Optimization Trial.

Authors:  Oliver J Ott; Carolin Jeremias; Udo S Gaipl; Benjamin Frey; Manfred Schmidt; Rainer Fietkau
Journal:  Strahlenther Onkol       Date:  2015-09-14       Impact factor: 3.621

10.  Radiotherapy for benign calcaneodynia: long-term results of the Erlangen Dose Optimization (EDO) trial.

Authors:  Oliver J Ott; Carolin Jeremias; Udo S Gaipl; Benjamin Frey; Manfred Schmidt; Rainer Fietkau
Journal:  Strahlenther Onkol       Date:  2014-03-26       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.